Philippe Rousselot

Philippe Rousselot

UNVERIFIED PROFILE

Are you Philippe Rousselot?   Register this Author

Register author
Philippe Rousselot

Philippe Rousselot

Publications by authors named "Philippe Rousselot"

Are you Philippe Rousselot?   Register this Author

100Publications

4287Reads

49Profile Views

The story of tyrosine kinase inhibitors discontinuation in clinical practice.

Leuk Lymphoma 2018 12 18;59(12):2782-2791. Epub 2018 Jun 18.

a Department of Hematology and Oncology , Université Versailles Saint-Quentin-en-Yvelines, Université Paris Saclay, INSERM U1173, Centre Hospitalier de Versailles , Le Chesnay , France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2018.1459611DOI Listing
December 2018

Nivolumab to control molecular response in chronic myeloid leukemia.

Leuk Res 2018 09 26;72:5-6. Epub 2018 Jul 26.

General and Oncologic Dermatology department, Hôpital Ambroise-Paré, AP-HP, Boulogne, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2018.07.011DOI Listing
September 2018

Intensified Therapy of Acute Lymphoblastic Leukemia in Adults: Report of the Randomized GRAALL-2005 Clinical Trial.

J Clin Oncol 2018 08 4;36(24):2514-2523. Epub 2018 Jun 4.

Françoise Huguet, Eric Delabesse, Institut Universitaire du Cancer, Toulouse; Sylvie Chevret, Nicolas Boissel, Hervé Dombret, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris (AP-HP); Université Paris Diderot; Agnès Buzyn, Vahid Asnafi, Elizabeth Macintyre, Hôpital Necker, AP-HP; Université Paris Descartes, Paris; Thibaut Leguay, Centre Hospitalier Universitaire, Pessac; Xavier Thomas, Véronique Lhéritier, Hôpital Lyon-Sud, Pierre Bénite; Martine Escoffre-Barbe, Centre Hospitalier Universitaire, Rennes; Patrice Chevallier, Marie C. Béné, Centre Hospitalier Universitaire, Nantes; Mathilde Hunault, Norbert Ifrah, Centre Hospitalier Universitaire, Angers; Norbert Vey, Institut Paoli-Calmettes, Marseille; Caroline Bonmati, Centre Hospitalier Universitaire, Nancy; Stéphane Lepretre, Centre Henri Becquerel, Rouen; Jean-Pierre Marolleau, Centre Hospitalier Universitaire, Amiens; Philippe Rousselot, Centre Hospitalier, Versailles; Jean-Yves Cahn, Centre Hospitalier Universitaire Grenoble-Alpes, La Tronche, France; Thomas Pabst, Inselspital; Swiss Group for Clinical Cancer Research, Bern; and Yves Chalandon, Swiss Group for Clinical Cancer Research, Bern; Hôpital Universitaire, Geneva, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.76.8192DOI Listing
August 2018

The rising prevalence of chronic myeloid leukemia in France.

Leuk Res 2018 06 17;69:94-99. Epub 2018 Apr 17.

Institut Gustave Roussy, Service de Biostatistique et d'Epidémiologie, Villejuif, F-94805, France; CESP, Centre for Research in Epidemiology and Population Health, INSERM U1018, Paris-Sud Univ., Villejuif, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2018.04.008DOI Listing
June 2018

Dasatinib dose management for the treatment of chronic myeloid leukemia.

Cancer 2018 04 25;124(8):1660-1672. Epub 2018 Jan 25.

Department of Hematology and Oncology, Versailles Medical Center, INSERM UMR 1173, University of Versailles Saint-Quenti-en-Yvelines, Paris Saclay, Le Chesnay, France.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/cncr.31232
Publisher Site
http://dx.doi.org/10.1002/cncr.31232DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5901015PMC
April 2018

Bone marrow mesenchymal stromal cell (MSC) gene profiling in chronic myeloid leukemia (CML) patients at diagnosis and in deep molecular response induced by tyrosine kinase inhibitors (TKIs).

Leuk Res 2017 09 26;60:94-102. Epub 2017 Jul 26.

INSERM, U935, F-86000 Poitiers, France; Hôpital Paul Brousse, Service d'Hématologie Biologique, F-94800 Villejuif, France; NSERM U935, F-94807 Villejuif, France; Université Paris Sud, F-94270 Le Kremlin-Bicêtre, France; Hôpital Bicêtre, Service d'Hématologie Biologique, F-94270 Le Kremlin Bicêtre, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2017.07.007DOI Listing
September 2017

Bosutinib-related pneumonitis.

Eur Respir J 2017 09 12;50(3). Epub 2017 Sep 12.

AP-HP, Hôpital Saint-Louis, Service de Pneumologie, Paris, France

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1183/13993003.00930-2017DOI Listing
September 2017

Long-Term Follow-Up of the French Stop Imatinib (STIM1) Study in Patients With Chronic Myeloid Leukemia.

J Clin Oncol 2017 Jan 31;35(3):298-305. Epub 2016 Oct 31.

Gabriel Etienne and François-Xavier Mahon, Institut Bergonié, Bordeaux; Joëlle Guilhot and François Guilhot, Institut National de la Santé et de la Recherche Médicale (INSERM), Centre Hospitalier Universitaire (CHU) de Poitiers, Poitiers; Delphine Rea, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris (AP-HP); Bruno Varet, Hôpital Necker, AP-HP et Université Paris Descartes, Paris; Françoise Rigal-Huguet, Institut Universitaire du Cancer Toulouse-Oncopole, Toulouse; Franck Nicolini, Centre Hospitalier Lyon Sud, Pierre Bénite; Aude Charbonnier, Institut Paoli Calmette, Marseille; Agnès Guerci-Bresler, CHU Brabois Vandoeuvre, Nancy; Laurence Legros, Hôpital de l'Archet, Centre Hospitalier Universitaire de Nice, Nice; Martine Gardembas, CHU d'Angers, Angers; Viviane Dubruille, CHU Hôtel-Dieu, Nantes; Michel Tulliez, Hôpital Henri Mondor, Créteil; Marie-Pierre Noel, Hôpital Claude Huriez, Centre Hospitalier Regional Universitaire de Lille, Lille; Jean-Christophe Ianotto, CHU Morvan, Brest; Bruno Villemagne, Centre Hospitalier Départemental La Roche-Sur-Yon, La Roche-Sur-Yon; Martin Carré, Hôpital Albert Michallon, CHU de Grenoble, Grenoble; Philippe Rousselot, Hôpital André Mignot, Le Chesnay; and François-Xavier Mahon, CHU de Bordeaux, INSERM U1218, Bordeaux, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.68.2914DOI Listing
January 2017

Imatinib Increases Serum Creatinine by Inhibiting Its Tubular Secretion in a Reversible Fashion in Chronic Myeloid Leukemia.

Clin Lymphoma Myeloma Leuk 2016 Mar 20;16(3):169-74. Epub 2015 Dec 20.

Department of Renal Physiology, DHU Fire, Bichat Hospital, AP-HP, Paris, France; Université Paris Diderot, Sorbonne Paris Cité, Paris, France; INSERM, U1149, Centre de Recherche sur l'Inflammation, Paris, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2015.12.001DOI Listing
March 2016

Methane clathrates in the solar system.

Astrobiology 2015 Apr 16;15(4):308-26. Epub 2015 Mar 16.

1 Aix Marseille Université , CNRS, LAM (Laboratoire d'Astrophysique de Marseille) UMR 7326, Marseille, France .

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/ast.2014.1189DOI Listing
April 2015

Loss of major molecular response as a trigger for restarting tyrosine kinase inhibitor therapy in patients with chronic-phase chronic myelogenous leukemia who have stopped imatinib after durable undetectable disease.

J Clin Oncol 2014 Feb 9;32(5):424-30. Epub 2013 Dec 9.

Philippe Rousselot, Hôpital Mignot, Université Versailles Saint-Quentin-en-Yvelines, Versailles; Aude Charbonnier, Institut Paoli Calmette, Marseille; Pascale Cony-Makhoul, Hôpital d'Annecy, Pringy; Philippe Agape, Hôpital Felix Guyon-Centre Hospitalier Universitaire en France (CHU) de la Réunion, La Réunion; Franck E. Nicolini, Centre Hospitalier Lyon Sud, Pierre-Bénite; Bruno Varet, Hôpital Necker, Assistance Publique-Hopitaux de Paris (AP-HP) et Université Paris Descartes; Delphine Réa and Jean Michel Cayuela, Hôpital Saint-Louis, AP-HP, Paris; Martine Gardembas, CHU d'Angers, Angers; Gabriel Etienne and Josy Reiffers, Institut Bergonié; François-Xavier Mahon, Hôpital Haut-Levèque et Université Bordeaux Ségalen, Bordeaux; Lydia Roy, Joëlle Guilhot, and François Guilhot, Institut National de la Santé et de la Recherche Médicale (INSERM) Centres d'Investigation Clinique CHU de Poitiers, Poitiers; Martine Escoffre-Barbe, Centre Hospitalier Pontchaillou, Rennes; Agnès Guerci-Bresler, CHU Brabois Vandoeuvre, Nancy; Michel Tulliez, Hôpital Henri Mondor, AP-HP, Créteil; Stéphane Prost, Commissariat à l'Énergie Atomique et aux Énergies Alternatives, Institute of Emerging Diseases and Innovative Therapies, Fontenay-aux-Roses; Marc Spentchian, Hôpital Mignot, Le Chesnay; and Jean Claude Chomel and Ali Turhan, INSERM U935, Université Poitiers et Paris Sud, Le Kremlin Bicêtre, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2012.48.5797DOI Listing
February 2014

The Spectrum of FIP1L1-PDGFRA-Associated Chronic Eosinophilic Leukemia: New Insights Based on a Survey of 44 Cases.

Medicine (Baltimore) 2013 Sep;92(5):e1-e9

From the French Eosinophil Network-EA-2686 and Department of Immunology (FL, SM, DL, SD, LP, JEK); Laboratory of Hematology, INSERM U837-Institut de Recherche contre le Cancer (AR, CP); Department of Internal Medicine (PYH); and INSERM U995 (MC), CHRU de Lille, Université Lille-Nord de France, Lille; CNRS UMR 8147 and Department of Hematology (EM), Hôpital Necker-Enfants Malades Assistance Publique-Hôpitaux de Paris (AP-HP), Université Paris-5 Descartes, Paris; Department of Internal Medicine (FA, OB, JEK), Hôpital Foch, Université Versailles Saint-Quentin en Yvelines, Suresnes; Laboratory of Hematology (JMC), Hôpital Saint-Louis (AP-HP), Université Paris-7 Diderot, Paris; Department of Hematology (PR), Hôpital André Mignot, Université Versailles Saint-Quentin en Yvelines, Le Chesnay; Department of Hematology (AST), CHU Angers, Angers; Department of Internal Medicine (OF), Hôpital Jean Verdier (AP-HP), Bondy; Department of Internal Medicine (MM), Hôpital Henri Mondor (AP-HP), Créteil; Department of Internal Medicine and Oncology (JPdJ), Hôpital d'Instruction des Armées Sainte-Anne, Toulon; Department of Hematology (PCM), Centre Hospitalier d'Annecy, Pringy; Department of Internal Medicine (DS), Hôpital Lariboisière (AP-HP), Paris; Department of Pneumology (VC), Hôpital Louis Pradel-Hospices Civils de Lyon, Lyon; Department of Internal Medicine A (MH), CHU Hotel-Dieu, Nantes; Department of Internal Medicine (OL), Hôpital Bichat-Claude Bernard (AP-HP), Paris; and Department of Pediatric Hematology (AB), Hôpital Robert Debré (AP-HP), Paris; France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MD.0b013e3182a71ebaDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4553979PMC
September 2013

Curing chronic myeloid leukemia.

Curr Hematol Malig Rep 2012 Jun;7(2):103-8

Service des Maladies du Sang et EA3518, Hôpital Saint-Louis, AP-HP, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11899-012-0117-2DOI Listing
June 2012

Minimal residual disease monitoring based on FLT3 internal tandem duplication in adult acute myeloid leukemia.

Leuk Res 2012 Mar 29;36(3):316-23. Epub 2011 Nov 29.

UR Biologie Moléculaire des leucémies et lymphomes, Faculté de Médecine de Sousse, Université de Sousse, Tunisia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2011.11.002DOI Listing
March 2012

Eradication of acute promyelocytic leukemia-initiating cells through PML-RARA degradation.

Nat Med 2008 Dec 23;14(12):1333-42. Epub 2008 Nov 23.

Université de Paris 7/CNRS UMR 7151, Equipe labellisée N degrees 11 Ligue Nationale Contre le Cancer, Service de Biochimie, Hôpital St Louis, Paris Cedex 10, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nm.1891DOI Listing
December 2008

Lung abnormalities after dasatinib treatment for chronic myeloid leukemia: a case series.

Am J Respir Crit Care Med 2007 Oct 28;176(8):814-8. Epub 2007 Jun 28.

Université Denis Diderot-Paris 7, Assistance Publique-Hôpitaux de Paris, Service de Pneumologie, Hôpital Saint-Louis 1, Avenue Claude Vellefaux, 75475 Paris, Cedex 10, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1164/rccm.200705-715CRDOI Listing
October 2007

Frequent antibody production against RARalpha in both APL mice and patients.

Blood 2006 Sep 25;108(6):1972-4. Epub 2006 May 25.

INSERM UMR S 718, Institut Universitaire d'Hématologie (IUH), Hôpital Saint-Louis, 1 Avenue Claude Vellefaux, Paris Cedex 10, F-75475 France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2006-03-013177DOI Listing
September 2006

Diagnostics, prognostic and therapeutic exploitation of telomeres and telomerase in leukemias.

Curr Pharm Biotechnol 2006 Jun;7(3):171-83

INSERM U685, Hôpital Saint-Louis, 75010 Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2174/138920106777549768DOI Listing
June 2006

BCR/ABL oncogene directly controls MHC class I chain-related molecule A expression in chronic myelogenous leukemia.

J Immunol 2006 Apr;176(8):5108-16

Institut National de la Santé et de la Recherche Médicale, Unité 622, Centre d'Investigations Biomédicales, Laboratoire d'Immunologie et d'Histocompatibilité, Hôpital Saint-Louis, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4049/jimmunol.176.8.5108DOI Listing
April 2006